WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Ty Kayam
Of Counsel
Regulatory
Seattle
tkayam@wsgr.com

D206-883-2607

Download vCard
Open PDF

Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she advises companies and investors working at the intersection of healthcare, artificial intelligence, software, and data.

Ty’s practice is informed by direct experience working with generative AI, wearables, robotics, and other emerging technologies that do not fit neatly within existing regulatory frameworks. Ty counsels clients on regulatory matters across the lifecycle of health technology products, including those that arise in developing, deploying, financing, and acquiring these products. Ty also advises on health data exchange, interoperability, and information blocking, including related obligations that arise when products connect to EHRs, health information networks, and other connected devices or systems.

Prior to joining the firm, Ty served as the first attorney in the FDA’s Digital Health Center of Excellence. Her work addressed legal and policy questions involving digital health, software, AI-enabled medical technologies, lifecycle regulation, predetermined change control plans, and pre- and post-market issues for novel software-enabled products. She has also worked across FDA, other federal agencies, and international partners on regulatory alignment for digital health and AI.  

Earlier, Ty was senior corporate counsel at Microsoft, where she advised product and business teams developing and commercializing health AI and digital health technologies. She counseled teams on product development, enterprise deployments, data licensing, strategic partnerships, and global regulatory and policy strategy for emerging health technology products.

Ty has taught health technology law as an adjunct professor at Seattle University School of Law and has guest lectured at the University of Ottawa, Florida University, American University, and other institutions. Her background in science, public policy, and technology informs her work with companies developing health products in regulated markets.

Ty is fluent in Telugu.

Experience

Ty Kayam is Of Counsel in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she advises companies and investors working at the intersection of healthcare, artificial intelligence, software, and data.

Ty’s practice is informed by direct experience working with generative AI, wearables, robotics, and other emerging technologies that do not fit neatly within existing regulatory frameworks. Ty counsels clients on regulatory matters across the lifecycle of health technology products, including those that arise in developing, deploying, financing, and acquiring these products. Ty also advises on health data exchange, interoperability, and information blocking, including related obligations that arise when products connect to EHRs, health information networks, and other connected devices or systems.

Prior to joining the firm, Ty served as the first attorney in the FDA’s Digital Health Center of Excellence. Her work addressed legal and policy questions involving digital health, software, AI-enabled medical technologies, lifecycle regulation, predetermined change control plans, and pre- and post-market issues for novel software-enabled products. She has also worked across FDA, other federal agencies, and international partners on regulatory alignment for digital health and AI.  

Earlier, Ty was senior corporate counsel at Microsoft, where she advised product and business teams developing and commercializing health AI and digital health technologies. She counseled teams on product development, enterprise deployments, data licensing, strategic partnerships, and global regulatory and policy strategy for emerging health technology products.

Ty has taught health technology law as an adjunct professor at Seattle University School of Law and has guest lectured at the University of Ottawa, Florida University, American University, and other institutions. Her background in science, public policy, and technology informs her work with companies developing health products in regulated markets.

Ty is fluent in Telugu.

Education
  • J.D., Northeastern University School of Law, 2016

    Editor, Northeastern Law Review; Health Law Moot Court Program

  • M.P.H., Tufts University, 2016
  • B.S., Biology, Acadia University, 2013Concentration in Genetics, Minor in Chemistry
Associations and Memberships
  • Vice Chair, eHealth, Privacy, and Security Committee, American Bar Association, Health Law Section, 2020-2021, 2022-2023
  • Vice Chair, Cybersecurity Task Force, American Bar Association, Health Law Section, 2021-2023
  • Health Information and Technology Practice Group, American Health Law Association, 2021-2023
  • Co-Chair, Women in Health & Life Sciences Law, National Association of Women Lawyers, 2020-2021
Honors
  • Recipient of the 2025 FDA Digital Health Above and Beyond Award
  • Named 2023 Emerging Young Lawyer in Healthcare by the American Bar Association’s Health Law Section
  • Named 2021 Rising Star by the National Association of Women Lawyers
Admissions
  • Bar of the District of Columbia
  • State Bar of Massachusetts
Credentials
Education
  • J.D., Northeastern University School of Law, 2016

    Editor, Northeastern Law Review; Health Law Moot Court Program

  • M.P.H., Tufts University, 2016
  • B.S., Biology, Acadia University, 2013Concentration in Genetics, Minor in Chemistry
Associations and Memberships
  • Vice Chair, eHealth, Privacy, and Security Committee, American Bar Association, Health Law Section, 2020-2021, 2022-2023
  • Vice Chair, Cybersecurity Task Force, American Bar Association, Health Law Section, 2021-2023
  • Health Information and Technology Practice Group, American Health Law Association, 2021-2023
  • Co-Chair, Women in Health & Life Sciences Law, National Association of Women Lawyers, 2020-2021
Honors
  • Recipient of the 2025 FDA Digital Health Above and Beyond Award
  • Named 2023 Emerging Young Lawyer in Healthcare by the American Bar Association’s Health Law Section
  • Named 2021 Rising Star by the National Association of Women Lawyers
Admissions
  • Bar of the District of Columbia
  • State Bar of Massachusetts

Select Publications

  • Co-author, “Health Care Regulatory Diligence Considerations for Digital Health Transactions,” American Health Law Association, April 21, 2022
  • Co-author, “Privacy as a competitive differentiator: Building an effective and strategic healthcare privacy program,” IAPP, October 20, 2021
  • Co-author, “Will You Share My Data, Please? Evolving Legal Frameworks to Address Information Sharing by and for Patients,” The SciTech Journal, June 30, 2021
  • Co-author, “Connected Devices in Healthcare: Current Legal Framework,” American Health Law Association, January 1, 2019

Select Speaking Engagements

  • Speaker, “Digital Transformation in Healthcare & Regulatory Innovation,” Women in Bio Seattle and ORCA, Seattle, Washington, 2025
  • Speaker, “AI for Health & Research: Policy, Practice and Governance,” Data Privacy for Health & Life Sciences Summit, San Francisco, California, 2025
  • Speaker, “Where AI Meets Humanity in Healthcare: What’s Next?” Seattle University Ethics & Tech Conference, Seattle, Washington, 2024
  • Speaker, “Artificial Intelligence: Recent Developments and Hot Topics,” American Health Law Association Annual Meeting, Washington, D.C., 2024
  • Speaker, Digital Health Counsel 2024 and 2025 AI Summit, Seattle, Washington
Insights

Select Publications

  • Co-author, “Health Care Regulatory Diligence Considerations for Digital Health Transactions,” American Health Law Association, April 21, 2022
  • Co-author, “Privacy as a competitive differentiator: Building an effective and strategic healthcare privacy program,” IAPP, October 20, 2021
  • Co-author, “Will You Share My Data, Please? Evolving Legal Frameworks to Address Information Sharing by and for Patients,” The SciTech Journal, June 30, 2021
  • Co-author, “Connected Devices in Healthcare: Current Legal Framework,” American Health Law Association, January 1, 2019

Select Speaking Engagements

  • Speaker, “Digital Transformation in Healthcare & Regulatory Innovation,” Women in Bio Seattle and ORCA, Seattle, Washington, 2025
  • Speaker, “AI for Health & Research: Policy, Practice and Governance,” Data Privacy for Health & Life Sciences Summit, San Francisco, California, 2025
  • Speaker, “Where AI Meets Humanity in Healthcare: What’s Next?” Seattle University Ethics & Tech Conference, Seattle, Washington, 2024
  • Speaker, “Artificial Intelligence: Recent Developments and Hot Topics,” American Health Law Association Annual Meeting, Washington, D.C., 2024
  • Speaker, Digital Health Counsel 2024 and 2025 AI Summit, Seattle, Washington
Focus Areas
  • AI in Healthcare
  • Artificial Intelligence and Machine Learning
  • Biotech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • FDA Regulatory, Healthcare, and Consumer Products
  • Life Sciences
  • Medical Devices
  • Regulatory
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.